iFlash-2019-nCoV Neutralization Antibody Test
iFlash-2019-nCoV NAb (Neutralization Antibody) assay is a chemiluminescence immunoassay (CLIA) for the qualitative determination of 2019-nCoV Neutralization Antibodies in human serum or plasma. This assay can simulate the in vivo binding of SARS-CoV-2 RBD to ACE2-receptor in human host cells after SARS-CoV-2 infection or vaccination.
- Evaluate COVID-19 vaccines development and efficacy
- Monitor the NAb titers in COVID-19 patients and vaccinated individuals.
- Analyze herd immunity status to guide policymakers.
- Monitoring in during convalescent plasma therapy or other antibody related treatments.